This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Organogenesis Inc., a leading regenerative medicine company specializing in advanced wound care, surgical biologics, and tissue regeneration products. The $1,239.95 fixed-price delivery order is for the supply of the APLIGRAF wound care product.
Organogenesis holds several significant federal Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs (VA) and DLA, valued at up to $25 million, $30 million, and $49.5 million, for the provision of a comprehensive range of regenerative medicine products to support medical treatments across military and veteran healthcare systems. This particular delivery order does not utilize a set-aside designation, but Organogenesis has been a recipient of contracts through small business programs in the past. The contract has an ultimate completion date of November 25, 2024.
Generated 2/19/25, 9:03 AM